HCA Healthcare Inc [HCA] stock is trading at $321.50, up 0.29%. An important factor to consider is whether the stock is rising or falling in short-term value. The HCA shares have gain 2.92% over the last week, with a monthly amount glided 0.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wells Fargo downgraded its rating to Underweight on November 25, 2024, and dropped its price target to $320. On November 22, 2024, downgrade downgraded it’s rating to Mkt Perform. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $475 on October 11, 2024. Morgan Stanley initiated its recommendation with a Equal-Weight and recommended $427 as its price target on September 03, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 30, 2024, and assigned it a price target of $396. In a note dated March 06, 2024, Barclays initiated an Overweight rating and provided a target price of $356 on this stock.
HCA Healthcare Inc [HCA] stock has fluctuated between $289.98 and $417.14 over the past year. Currently, Wall Street analysts expect the stock to reach $409 within the next 12 months. HCA Healthcare Inc [NYSE: HCA] shares were valued at $321.50 at the most recent close of the market. An investor can expect a potential return of 27.22% based on the average HCA price forecast.
Analyzing the HCA fundamentals
HCA Healthcare Inc [NYSE:HCA] reported sales of 70.60B for the trailing twelve months, which represents a growth of 5.68%. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is -2.92 and Total Capital is 0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-18.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 319.03 points at the first support level, and at 316.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 324.65, and for the 2nd resistance point, it is at 327.80.
Ratios To Look Out For
For context, HCA Healthcare Inc’s Current Ratio is 1.08. On the other hand, the Quick Ratio is 0.97, and the Cash Ratio is 0.15. Considering the valuation of this stock, the price to sales ratio is 1.13 and price to earnings (TTM) ratio is 14.62.
Transactions by insiders
Recent insider trading involved Berres Jennifer, SVP & Chief Human Res. Officer, that happened on Feb 14 ’25 when 9533.0 shares were sold. Officer, Berres Jennifer completed a deal on Feb 14 ’25 to buy 9533.0 shares. Meanwhile, Former Officer Reiner Deborah M bought 3510.0 shares on Feb 11 ’25.
